Upgrade to SI Premium - Free Trial

Biogen (BIIB) Plans to Spinoff Hemophilia Business into Independent, Publicly-Traded Company

May 3, 2016 7:31 AM
Biogen Inc. (NASDAQ: BIIB) announced that it intends to spin off its hemophilia business as an independent, publicly traded company ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Hot Corp. News Hot IPOs IPOs Management Comments Spinoffs

Next Articles